Motif Neurotech Raises $18.75M for Implantable Device for Treatment-Resistant Depression
What You Should Know:
– Motif Neurotech, a pioneer in minimally-invasive bioelectronics for mental health, announced today an impressive $18.75 million Series A funding round. Led by Arboretum Ventures, the investment saw participation from prominent…
Continue Reading